Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 16380627.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Associations between clinical phenotype (muscle weakness, dilated cardiomyopathy) and dystrophin abnormalities in muscle tissue among definite carriers of Duchenne (DMD) and Becker muscular dystrophy (BMD) were investigated. No associations between dystrophin abnormalities and clinical variables in DMD/BMD carriers were found. Because 26% of nonmanifesting carriers have dystrophin-negative fibers, this might be used in suspected DMD/BMD carriers in whom DNA analysis fails to give an answer about their carrier risk.
Medical subject headings
- Dystrophin
- Genetic Predisposition to Disease
- Heterozygote
- Muscular Dystrophy, Duchenne